Selected article for: "acute respiratory syndrome and longitudinal sectional"

Author: Leong, Hoe Nam; Chan, Kwai Peng; Khan, Ali S.; Oon, Lynette; Se-Thoe, Su Yun; Bai, Xin Lai; Yeo, Daniel; Leo, Yee Sin; Ang, Brenda; Ksiazek, Thomas G.; Ling, Ai Ee
Title: Virus-specific RNA and Antibody from Convalescent-phase SARS Patients Discharged from Hospital
  • Cord-id: fk7qb4ui
  • Document date: 2004_10_25
  • ID: fk7qb4ui
    Snippet: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus (SARS-CoV). In a longitudinal cross-sectional study, we determined the prevalence of virus in bodily excretions and time of seroconversion in discharged patients with SARS. Conjunctival, throat, stool, and urine specimens were collected weekly from 64 patients and tested for SARS-CoV RNA by real-time polymerase chain reaction; serum samples were collected weekly and tested for SARS-CoV antibody with indirect enzyme immunoa
    Document: Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus (SARS-CoV). In a longitudinal cross-sectional study, we determined the prevalence of virus in bodily excretions and time of seroconversion in discharged patients with SARS. Conjunctival, throat, stool, and urine specimens were collected weekly from 64 patients and tested for SARS-CoV RNA by real-time polymerase chain reaction; serum samples were collected weekly and tested for SARS-CoV antibody with indirect enzyme immunoassay and immunofluorescence assay. In total, 126 conjunctival, 124 throat swab, 116 stool, and 124 urine specimens were analyzed. Five patients had positive stool samples, collected in weeks 5–9. Two patients seroconverted in weeks 7 and 8; the others were seropositive at the first serum sample collection. In this study, 5 (7.8%) of 64 patients continued to shed viral RNA in stool samples only, for up to week 8 of illness. Most seroconversions occurred by week 6 of illness.

    Search related documents:
    Co phrase search for related documents
    • acid amplification test and acute phase: 1
    • acid amplification test and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active replication and acute phase: 1
    • active replication and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active replication and additional patient: 1
    • acute phase and additional patient: 1
    • acute phase and local transmission: 1, 2
    • acute phase and long hospital stay: 1
    • acute respiratory syndrome and additional patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • acute respiratory syndrome and local hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and local transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and long hospital stay: 1, 2, 3
    • acute respiratory syndrome and longitudinal cross sectional study: 1, 2, 3, 4
    • additional patient and local hospital: 1
    • additional patient and local transmission: 1
    • additional patient and long hospital stay: 1